1. Long-term (5–11 years) follow-up of general immune competence in breast cancer

   • Hari S. Shukla
   • Leslie E. Hughes
   • Robert G. Newcombe

   Original Articles Pages: 1 - 5

2. Long-term follow-up of general immune competence in breast cancer

   • Hari S. Shukla
   • Leslie E. Hughes
   • Robert G. Newcombe

   Original Articles Pages: 6 - 11

3. Augmentation of the therapeutic efficacy of adoptive tumor immunotherapy by in vivo administration of slowly released recombinant interleukin 2

   • Takashi Nishimura
   • Yuji Togashi
   • Yoshiyuki Hashimoto

   Original Articles Pages: 12 - 18

4. Augmentation of NK activity and/or macrophage-mediated cytotoxicity in the liver by biological response modifiers including human recombinant interleukin 2

   • Shu-Ren Zhang
   • Raoul R. Salup
   • Robert H. Wiltrout

   Original Articles Pages: 19 - 25

5. The effect of RU 41.740 (Biostim) on the production of interleukin-1 by monocytes and enriched large granular lymphocytes in normals and patients with hepatocellular carcinoma

   • Jean Herman
   • Michael C. Kew
   • Arthur R. Rabson

   Original Articles Pages: 26 - 30

6. Relation between the site of primary intracranial tumors and mitogenic responses of blood lymphocytes

   • Henric Blomgren
   • Ulla Blom
   • Henrik Ullén

   Original Articles Pages: 31 - 38

7. Correlation of tumor specific delayed type hypersensitivity reaction and tumor protection to SV₄₀-induced mKSA fibrosarcoma

   • Salam Kadhim
   • John Barrington-Leigh

   Original Articles Pages: 39 - 44

8. Development of highly immunogenic variants of a rat fibrosarcoma line during in vitro cultivation

   • Kenji Yamashina
   • Tusuneyuki Oikawa
   • Hiroshi Kobayashi

   Original Articles Pages: 45 - 50

9. Suppression of murine NK activity induced by Corynebacterium parvum

   • Vita K. Milisauskas
   • Gustavo Cudkowicz
   • Ichiro Nakamura

   Original Articles Pages: 51 - 57

10. Metastatic phenotype of human prostate tumor cells in athymic nude mice: Alteration by exposure to ethyl methanesulfonate and “reversion” by 5-azacytidine

    • Joy L. Ware
    • Andrew P. Lieberman
    • Karen S. Webb

    Original Articles Pages: 58 - 62

11. Activation of antitumor properties in alveolar macrophages from protein-calorie malnourished rats

    • Seiji Mutsuura
    • Saburo Sone
    • Yasuo Kishino

    Original Articles Pages: 63 - 68

12. Lysis of autologous tumor cells by blood lymphocytes tested at the time of surgery

    • Farkas Vánky
    • Eva Klein
    • Tomas Aparisi

    Original Articles Pages: 69 - 76

13. WEHI 164 sarcoma cells rendered resistant to monocyte-released cytotoxin are also resistant to monocyte-induced cytolysis

    • Odd Kildahl-Andersen
    • Rigmor Austgulen
    • Jon Nissen-Meyer

    Short Communication Pages: 77 - 80

14. Clinical and immunological evaluation of 20 patients with advanced colorectal cancer treated with high dose recombinant leukocyte interferon-αA (rIFNαA)

    • Alexander M. Eggermont
    • Willem Weimar
    • Johannes Jeekel

    Short Communication Pages: 81 - 84